Overview

• The national public health emergency formally ended after a reported 104 million U.S. cases and 1.1 million deaths.
• The FDA said the next fall COVID-19 vaccines would target a recent Omicron-lineage strain to improve protection.
• U.S. health advisers backed Pfizer’s Paxlovid for high‑risk adults, clearing a path toward full FDA approval.
• The CDC and FDA warned Florida’s surgeon general in a letter that his statements on COVID-19 risks were harmful to the public.
• People reporting vaccine-related injuries, including a case following a Johnson & Johnson shot, continue to await government compensation.